Glover, Alison

Safety profile of autologous macrophage therapy for liver cirrhosis

Moroni, F., Dwyer, B. J., Graham, C., Pass, C., Bailey, L., Ritchie, L., Mitchell, D., Glover, A., Laurie, A., Doig, S., et al. (2019) · Nature Medicine

Liver physiology and pathologyLiver Disease and Transplantation

Cited by 202

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine

Liver Disease and TransplantationLiver physiology and pathology

Cited by 66

LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial

Brennan, P., Macpherson, I., Troland, D., Kilpatrick, A. M., Manship, T., McGowan, N., Campbell, J., Fraser, A., Pass, C., Moroni, F., et al. (2024) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 3